Navigation Links
Rapid Generic Erosion of Branded Agents, Including Market-Leading Viagra, Will Cause Sales of Erectile Dysfunction Drugs to Remain Flat Over the Next Decade
Date:1/19/2009

However, Increases in the Drug Treated Population Will Temper Losses Incurred by Leading Agents, According to a New Report from Decision Resources

WALTHAM, Mass., Jan. 19 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the anticipated launch of five emerging drugs during the 2007-2017 forecast period, total sales for erectile dysfunction therapies will remain relatively constant, totaling $2.2 billion in 2007 and $2.1 billion in 2017. Rapid generic erosion, following patent expiries that begin in the United States in 2012 for the market leader, Pfizer's Viagra (sildenafil), will be the key event impacting the erectile dysfunction market. However, the decline in Viagra sales will be tempered by more widespread use of sildenafil overall, as greater numbers of patients are expected to seek treatment and receive prescription drug therapy for erectile dysfunction when less-expensive, generic versions of sildenafil become available.

The new Pharmacor report entitled Erectile Dysfunction finds that while therapeutic substitution of less-expensive, generic sildenafil for branded phosphodiesterase type 5 (PDE5) inhibitors will contribute to a significant loss of sales for Eli Lilly's Cialis and Bayer Healthcare/Schering-Plough/GlaxoSmithKline's Levitra, the availability of generic PDE5 inhibitors will encourage more patients to seek treatment for erectile dysfunction, driving increases in the diagnosed and drug-treated populations through 2017 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

According to the report, opportunity remains for emerging agents that can treat patients who do not respond to treatment with available PDE5 inhibitors or for whom these agents are contraindicated. However
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Allergy Sufferers to Benefit from New, Improved Rapid Relief Medication This Spring
2. First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center
3. Belmont(R) Rapid Infuser Helps Save Officers Life
4. Rapid Response Teams Dont Cut Hospital Heart Attacks, Death Rates
5. Ultrasound waves aid in rapid treatment of DVT
6. Frutarom Continues to Implement its Rapid Growth Strategy
7. New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections
8. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
9. Central California Doctors Now Using Fast RapidArc(TM) Radiotherapy Technology to Battle Cancer
10. Cancer Patients in Southeastern Florida Now Benefiting From RapidArc(TM) Radiotherapy Treatments
11. Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... YORK, NEW YORK (PRWEB) , ... June 29, ... ... sleep apnea (OSA) is now being offered at NewYork-Presbyterian/Weill Cornell Medical Center. The ... Drug Administration and is an alternative to continuous positive airway pressure (CPAP), the ...
(Date:6/29/2015)... ... 2015 , ... National HealthCare Associates recently released a list ... 40-center nursing home group. Sixteen of their centers were rated “Best in Class” ... one or more customer service areas. Those centers received the prestigious “Customer Experience ...
(Date:6/29/2015)... ... , ... With Urgent Care Medicine now serving a vital role in our ... Care Medicine and the Medical Society of Delaware to provide its latest professional development ... care professionals. , According to Matthew Bader, Exam Master CEO and President, “This resource ...
(Date:6/29/2015)... , ... June 29, 2015 , ... OR Manager announced ... revitalized look and feel, as well as a redesigned logo and weekly eLetter. The ... but is now more user-friendly and easier to navigate. , In addition to ...
(Date:6/29/2015)... ... ... The Food Safety and Technology Research Centre under the ... (PolyU) has developed a new method for rapid authentication of edible oils and ... in food safety, and becomes particularly important with the emergence and widespread use ...
Breaking Medicine News(10 mins):Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 4Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:OR Manager Launches New Website 2Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2
... , THURSDAY, Dec. 23 (HealthDay News) -- Flu activity in the ... but government health officials expect flu viruses will infect more people ... for Disease Control and Prevention has already received several reports of ... from New York and one from Texas. From Oct. 3 ...
... BOSTON--Dana Farber/Harvard Cancer Center (DF/HCC) will launch a new ... research. It will be administered in collaboration with the ... of the United States District Court for the District ... cy pres ("near as possible") distribution of unclaimed funds ...
... (HealthDay News) -- How do people recognize an image of a ... replica such as a doll or mannequin? A new study suggests ... distinguish real faces from those that are not. "There,s something ... are on and someone is home," study co-author Thalia Wheatley of ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, ... been able to help being so mean. That,s because ... less able to read the emotions of others, a new ... test how well participants could judge how others were feeling. ...
... , FRIDAY, Dec. 24 (HealthDay News) -- The lack ... Christmas may put their health at risk, British sleep experts ... may not harm Santa,s long-term health, there are short-term risks, ... the University of Warwick,s Warwick Medical School. The lack ...
... patients who stick to a vegetarian diet, according to a ... Journal of the American Society Nephrology (CJASN). The results ... disease patients avoid accumulating toxic levels of this mineral in ... the body of phosphorus, which is found in dietary proteins ...
Cached Medicine News:Health News:Flu Activity Low So Far, But More Cases to Come: CDC 2Health News:Dana Farber/Harvard Cancer Center awarded $11.7M grant to support prostate cancer research 2Health News:Maybe Scrooge Couldn't Help Being Hard-Hearted 2Health News:Maybe Scrooge Couldn't Help Being Hard-Hearted 3Health News:Could Santa's Lack of Sleep on Christmas Eve Harm His Health? 2Health News:Kidney disease patients: Eat your veggies, reward your kidneys 2
(Date:6/29/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... public offering of units. Each unit will consist of ... purchase common stock and Series B warrants to purchase ... offering would result in them beneficially owning more than ...
(Date:6/29/2015)... 29, 2015  Alimera Sciences, Inc. (NASDAQ: ALIM ... research, development and commercialization of prescription ophthalmic pharmaceuticals, today ... and Chief Financial Officer, will present at the 2015 ... at 8:00 a.m. ET at Le Parker Meridien Hotel ... The presentation will be webcast live and will be ...
(Date:6/29/2015)... , June 29, 2015 Regeneron ... that the Proceedings of the National Academy ... demonstrating that the Company,s proprietary VelociGene ® ... identification and preclinical validation of potential candidates that ... of Middle East Respiratory Syndrome (MERS). This involved ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5
... Athera Biotechnologies AB and Dyax,Corp. (NASDAQ: ... entered into a,collaboration to discover and to ... of cardiovascular inflammatory diseases., The collaboration ... Athera,scientific founders, Professors Frostegard and de Faire ...
... Amylin,s integrated neurohormonal ... approach to obesity pharmacotherapy, SAN DIEGO, Oct. 1 ... data for its pipeline obesity,candidates will be presented at the ... 3-7. The Obesity Society,s annual,meeting is one of the largest ...
Cached Medicine Technology:Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 2Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 3Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Ophthalmic Diagnostic Set with AutoStep Coaxial Ophthalmoscope, Spot Retinoscope, Rechargeable Handle, and Soft Case. High-quality eyecare from the preferred name in diagnostic instruments....
... are standard in all Welch Allyn ... students, the 18335-SDS combines the superior ... the superior illumination of the Halogen ... of the Finnoff Transilluminator, and the ...
High-quality eyecare from the preferred name in diagnostic instruments....
Medicine Products: